In-host modeling challenges using population approach methods

Fuente: arXiv
Guardado en:
Detalles Bibliográficos
Autores principales: Mhlanga, Adquate, Shekhtman, Louis, Goyal, Ashish, Degasperi, Elisabetta, Anolli, Maria Paola, Renteria, Sara Colonia Uceda, Sambarino, Dana, Borghi, Marta, Perbellini, Riccardo, Facchetti, Floriana, Callegaro, Annapaola, Cotler, Scott J., Lampertico, Pietro, Dahari, Harel
Formato: Preprint
Publicado: 2025
Materias:
Acceso en línea:
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
_version_ 1866916742316425216
author Mhlanga, Adquate
Shekhtman, Louis
Goyal, Ashish
Degasperi, Elisabetta
Anolli, Maria Paola
Renteria, Sara Colonia Uceda
Sambarino, Dana
Borghi, Marta
Perbellini, Riccardo
Facchetti, Floriana
Callegaro, Annapaola
Cotler, Scott J.
Lampertico, Pietro
Dahari, Harel
author_facet Mhlanga, Adquate
Shekhtman, Louis
Goyal, Ashish
Degasperi, Elisabetta
Anolli, Maria Paola
Renteria, Sara Colonia Uceda
Sambarino, Dana
Borghi, Marta
Perbellini, Riccardo
Facchetti, Floriana
Callegaro, Annapaola
Cotler, Scott J.
Lampertico, Pietro
Dahari, Harel
contents Non-linear mixed effects models are widely used to estimate parameter estimates in the field of pharmacometrics across pharmaceutical industry, US regulatory agencies and academia. The preciseness of the parameter estimate is evaluated using relative standard error (RSE) with a threshold of <50% considered as 'precisely estimated'. Here we investigate the use of this metric alone in Monolix to calibrate a recently published in-host mathematical model for hepatitis D virus (HDV) with our own longitudinal data obtained from patients treated with HDV-entry inhibitor bulevirtide (BLV) monotherapy for up to 96 weeks. We identified substantial discordance between Monolix calibration output, measured longitudinal data and the HDV model despite the fact that Monolix parameters had a RSE <50%, suggesting that model parameters were estimated with precision. Surprisingly, while Monolix suggested precise parameter estimates based on RSE<50%, the correlation matrix in Monolix indicated a strong inverse correlation between BLV efficacy and the loss rate of HDV-infected cells raising identifiability issues. Furthermore, the fits failed to reproduce HDV kinetics accurately in the majority of patients (i.e., poor goodness of fit). Lastly, the estimated pretreatment serum HDV level varied significantly from measured observations. In summary, we demonstrate that even when RSE was <50%, other outputs such as the correlation matrix, confidence intervals and goodness of fit at both the individual and population level need to be checked for accuracy to accept or refine a proposed model.
format Preprint
id arxiv_https___arxiv_org_abs_2505_12286
institution arXiv
publishDate 2025
record_format arxiv
spellingShingle In-host modeling challenges using population approach methods
Mhlanga, Adquate
Shekhtman, Louis
Goyal, Ashish
Degasperi, Elisabetta
Anolli, Maria Paola
Renteria, Sara Colonia Uceda
Sambarino, Dana
Borghi, Marta
Perbellini, Riccardo
Facchetti, Floriana
Callegaro, Annapaola
Cotler, Scott J.
Lampertico, Pietro
Dahari, Harel
Physics and Society
Other Quantitative Biology
Non-linear mixed effects models are widely used to estimate parameter estimates in the field of pharmacometrics across pharmaceutical industry, US regulatory agencies and academia. The preciseness of the parameter estimate is evaluated using relative standard error (RSE) with a threshold of <50% considered as 'precisely estimated'. Here we investigate the use of this metric alone in Monolix to calibrate a recently published in-host mathematical model for hepatitis D virus (HDV) with our own longitudinal data obtained from patients treated with HDV-entry inhibitor bulevirtide (BLV) monotherapy for up to 96 weeks. We identified substantial discordance between Monolix calibration output, measured longitudinal data and the HDV model despite the fact that Monolix parameters had a RSE <50%, suggesting that model parameters were estimated with precision. Surprisingly, while Monolix suggested precise parameter estimates based on RSE<50%, the correlation matrix in Monolix indicated a strong inverse correlation between BLV efficacy and the loss rate of HDV-infected cells raising identifiability issues. Furthermore, the fits failed to reproduce HDV kinetics accurately in the majority of patients (i.e., poor goodness of fit). Lastly, the estimated pretreatment serum HDV level varied significantly from measured observations. In summary, we demonstrate that even when RSE was <50%, other outputs such as the correlation matrix, confidence intervals and goodness of fit at both the individual and population level need to be checked for accuracy to accept or refine a proposed model.
title In-host modeling challenges using population approach methods
topic Physics and Society
Other Quantitative Biology
url https://arxiv.org/abs/2505.12286